Skip to main content
. 2021 May 29;13(6):813. doi: 10.3390/pharmaceutics13060813

Figure 5.

Figure 5

Observed and predicted fexuprazan concentration profiles at repeated doses of 40 mg/day (A) and 80 mg/day (B) on days 1, 5, 6, 7, 8, 9, 10, and 11 in Korean, Caucasian, and Japanese populations. Solid lines represent simulated results of optimized model or model prediction. Closed circles (●) represent observed data [1,23]. Data are means ± SD for 24 volunteers including all Korean, Caucasian, and Japanese populations.